Current Hepatitis Reports

, Volume 2, Issue 2, pp 63-70

First online:

Hepatitis B: Treatment strategies for currently available drugs

  • Robert P. PerrilloAffiliated withSection of Gastroenterology and Hepatology, Ochsner Clinic

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


There are three licensed drugs for chronic hepatitis B at the current time: interferon alpha, and the nucleoside analogues, lamivudine and adefovir. The benefits as well as limitations of each of these agents are described in this article. Preliminary studies suggest that the combination of interferon and lamivudine is associated with an enhanced rate of virologic response when compared with either agent alone.